Cadaveric allograft as adjunct therapy for nonhealing ulcers

Journal of Foot and Ankle Surgery

Volumn 38, Issue 2, 1999, Pages 93-101

  Snyder, Robert J ^a   Simonson, David A ^a  

^a Northwest Medical Center   (United States)

Author keywords

Allograft; Autograft; Homograft; Ulceration; Wounds

Indexed keywords

ADJUVANT THERAPY; ARTICLE; CADAVER DONOR; CLINICAL ARTICLE; CRYOPRESERVATION; DEBRIDEMENT; GRANULATION TISSUE; HUMAN; HUMAN TISSUE; SKIN ALLOGRAFT; SKIN ULCER; SOFT TISSUE INJURY; TREATMENT OUTCOME; WOUND CARE; WOUND DRESSING; WOUND HEALING IMPAIRMENT; WOUND INFECTION;

EID: 0032939538     PISSN: 10672516     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1067-2516(99)80019-2     Document Type: Article

References (27)

1. Xakellis, G. C., Frantz, R. The cost of healing pressure ulcers across multiple health care settings. Adv. Wound Care 9(6):18-22, 1996.
2. Taylor, D. D., Parris, R., Martin, A. M., Berk, W. A. Long-term costs for foot ulcers in diabetic patients in a multidisciplinary setting. Foot Ankle Int. 16(7):388-394, 1995.
3. Ashry, H. R., Lavery, L. A., Armstrong, D. G., Lavery, D. C., Van Houtum, W. H. Cost of diabetes-related amputations in minorities. J. Foot Ankle Surg. 37(3):186-190, 1998.
4. Tavis, M. J., Thornton, J., Danet, R., et al. Current status of skin substitures. Surg. Clin. North Am. 58:1233-1248, 1978.
5. Pollock, G. D. Cases of skin grafting and skin transplantation. Trans. Clin. Soc. Lond. 4:37, 1871.
6. Girdner, J. H. Skin-grafting with grafts taken from the dead subject. Med. Record 20:119, 1881.
7. Zaroff, L. I., Mills, W., Duckett, J. W., et al. Multiple uses of viable cutaneous homografts in the burned patient. Surgery 59:368, 1966
8. Pruitt, B. A., Levine, N. S. Characteristics and uses of biologic dressings and skin substitutes. Arch. Surg. 119:312-322, 1984.
9. Morris, P. J., Bondoc, C., Burke, J. F. The use of frequently changed skin allografts to promote healing in the nonhealing infected ulcer. Surgery 60(1):13-19, 1966.
10. Hackett, M., Bowen, J. Preliminary report on the comparative use of lyophilized homograft and xenograft in the closure of raw areas. Br. J. Surg. 61(6):427-429, 1974.
11. Hussmann, J., Russell, R. C., Kucan, J. O., Hebebrand, D., Bradely, T., Steinau, H. U. Use of glycerolized human allografts as temporary (and permanent) cover in adults and children. Burns 20(1):S61-S66, 1994.
12. Teepe, R. G. C., Koch, R., Haeseker, B. Randomized trial comparing cryopreserved cultured epidermal allografts with tulle-grass in the treatment of split-thickness skin graft donor sites. J. Trauma 35:6, 850-53, 1993.
13. Shuck, J. M., Bedeau, G. W., Thomas, P. R. S. Homograft skin for the early management of difficult wounds. J. Trauma 12(3):215-222, 1972.
14. Wood, W. B. Phagocytosis, with particular reference to encapsulated bacteria. Bacteriol. Rev. 24:41, 1960.
15. Burleson, R., Eisenman, B. Mechanisms of antibacterial effect of biological dressings. Ann. Surg. 177:181, 1973.
16. Bettman, A. G. Homogenous Thiersch grafting as a life saving measure. Am. J. Surg. 39:156, 1938.
17. Eade, G. G. The relationship between granulation tissue, bacteriam and skin grafts in burned patients. Plast. Reconstr. Surg. 22:42, 1958.
18. Spence, R. J., Wong, L. The enhancement of wound healing with human skin allograft. Wound Healing 77(3):731-745, 1997.
19. Shuck, J. M., Pruitt, B. A., Moncrief, J. A. Homograft skin for wound coverage: a study in versatility. Arch. Surg 98:472-479, 1969.
20. McCarthy, M. Bio-engineered tissues move towards the clinic. Lancet 348(9025):466, 1996.
21. Eaglstein, W. H., Falanga, V. Tissue engineering and the development of Apligraf, a human skin equivalent. Clin. Ther. 19(5):894-905, 1997.
22. Muhart, M., McFalls, S., Kirsner, R., Kerdel, F., Eaglstein, W. H. Bioengineered skin. Lancet 18:350(9085):1142, Oct. 1997.
23. Falanga, V., Margolis, D., Alvalez, O., Auletta, M., Maggiacomo, F., Altman, M., Jensen, J., Sabolinski, M. Hardin-Young, J. Rapid healing of venous ulcers and lack of clinical rejection with an allogeneic cultured human skin equivalent. Arch. Dermatol. 134:293-300, 1998.
24. Eaglstein, W. H., Iriondo, M., Laszlo, K. A composite skin substitute (graftskin) for surgical wounds. A clinical experience. Dermatol. Surg. 21(10):839-843, 1995.
25. Purdue, G. F., Junt, J. L., Stil, J. M., Law, E. J., Herndon, D. N., Goldfarb, W., Schiller, W. R., Hansboouough, J. F., Hickerson, W. L., Himel, H. N., Kealey, G. P., Twomey, J., Missavage, A. E., Solem, L. D., Davis, M., Totoritis, M., Gentzkow, G. D. A multicenter clinical trial of biosynthetic skin replacement, Dermagraft-TC, compared with cryopreserved human cadaver skin for temporary coverage of excised burn wounds. J. Burn Care Rehabil. 18(1) 1:52-57, 1997.
26. Hansbrough, J. F., Mozingo, D. W., Kealey, G. P., Davis, M., Gidner, A., Gentzkow, G. D. Clinical trials of biosynthetic temporary skin replacement, Dermagraft-Transitional Covering, compared with cryopreserved human cadaver skin for temporary coverage of excised bum wounds. J. Burn Care Rehabil. 18(1) 1:43-51, 1997.
27. Livesey, S , Atkinson, Y., Call, T., Griffey, S., Nag, A. An acellular dermal transplant processed from human cadaver skin retains normal extracellular matrix components and ultrastructural characteristics. Poster presented at the AATB Conference, Aug 20-24, 1994.